Fintel reports that on December 15, 2025, Oppenheimer maintained coverage of Ralliant (NYSE:RAL) with a Outperform ...
Fintel reports that on December 15, 2025, Oppenheimer maintained coverage of Praxis Precision Medicines (NasdaqGS:PRAX) with ...
8hon MSN
Oppenheimer Confident in Positive PROSERA Trial Readout in February 2026 for Gossamer Bio (GOSS)
Earlier on November 10, Oppenheimer analyst Andreas Argyrides raised the firm’s price target on Gossamer Bio to $12 from $9 ...
Adobe Inc. (NASDAQ:ADBE) is one of the Best SaaS Stocks to Buy Right Now. On December 12, Mark Moerdler from Bernstein ...
A key Google partner is starting to display home listing details directly in search results, prompting some industry experts ...
From Christian and Jewish screens to Shariah-compliant funds, faith-based investing is booming. See how investors are ...
Stocks wavered ahead of jobs data; Broadcom's tech slide impacts market sentiment. Fed Chair Jerome Powell faces pressure to ...
Investing.com -- IAC Inc. (NASDAQ:IAC) stock fell 3% after Oppenheimer analyst Jason S. Helfstein downgraded the company from Outperform to Perform, citing limited upside potential and concerns about ...
Asian equities expected to fall ahead of US jobs data, with global markets showing caution and defensive stance.
Dec 15 (Reuters) - Citigroup has set a year-end target of 7,700 for the S&P 500 index for 2026, pointing to robust ...
TheFly reported on December 5, 2025, that Oppenheimer analyst Rick Schafer had increased the firm’s price target for Broadcom ...
/Film on MSN
Emily Blunt Gave A Career-Defining Performance In Her Underrated Western Miniseries On Prime Video
Emily Blunt proved her drama chops in Prime Video's underrated Western miniseries The English, which co-stars the Twilight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback